FEN
N-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE
Find entries where: FEN
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | N-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE |
Identifiers | (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide |
Formula | C26 H33 N O2 |
Molecular Weight | 391.546 |
Type | NON-POLYMER |
Isomeric SMILES | CC1=C(C(CCC1)(C)C)\C=C\C(=C\C=C\C(=C\C(=O)Nc2ccc(cc2)O)\C)\C |
InChI | InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+ |
InChIKey | AKJHMTWEGVYYSE-FXILSDISSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 62 |
Chiral Atom Count | 0 |
Bond Count | 63 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB05076 |
---|---|
Name | Fenretinide |
Groups | investigational |
Description | A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. |
Synonyms |
|
Indication | Investigated for use/treatment in macular degeneration. |
Categories |
|
CAS number | 65646-68-6 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Retinol-binding protein 4 | MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDP... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL7301 |
PubChem | 5288209 |
ChEMBL | CHEMBL7301 |
ChEBI | CHEBI:42588, CHEBI:92493 |